{
    "type": "ETC",
    "ucits": false,
    "replication_method": "synthetic",
    "swaps": true,
    "derivatives": true,
    "leverage": false,
    "inverse": false,
    "complex_factors": [
        "Use of option writing strategy on MSTR stock",
        "Exposure via underlying ETF employing derivatives",
        "High risk rating (7/7)",
        "Structured income strategy with capped upside",
        "Counterparty risk inherent in ETC structure",
        "Physical backing by underlying ETF but underlying ETF uses derivatives"
    ],
    "classification": "complex",
    "supporting_data": "The product is an ETC (not a UCITS fund) that provides exposure to MicroStrategy stock via an underlying ETF (MSTY) which employs an option income strategy by writing call options on MSTR. This indicates derivative usage is inherent to the investment strategy, not merely for risk management. The ETC is physically backed by the underlying ETF but the underlying ETF itself uses derivatives extensively (option writing), which is a complexity factor. The KIID states a maximum risk rating of 7/7, the highest risk class, indicating very high risk and complexity. The ETC does not offer capital protection or guarantees and has counterparty risk exposure typical of ETCs. The strategy involves structured income with capped upside participation, which is a complex payoff profile. There is no mention of leverage or inverse exposure, but the use of derivatives and option strategies, combined with the ETC structure, leads to a classification as complex under MiFID II. The PRIIPs KID and factsheet confirm the use of option writing strategies, which are derivative-based and complex. The product is intended for investors with specific knowledge and experience, further supporting complexity. No simple physical replication or direct purchase of underlying securities is indicated; rather, exposure is via a derivative-based ETF. Therefore, the product is complex due to its synthetic replication via derivatives, structured option income strategy, and high risk profile."
}